Latest News

In a Q&A, Monique Hinchcliff, MD, MS, director of the Yale Scleroderma Program, discusses her work to accurately calculate the burden of calcinosis cutis deposits and why she hopes it will lead to more clinical trials to help find better treatments for patients.

Shivani Garg, MD, PhD, associate professor of medicine (rheumatology), director of the Lupus Clinical Research Program, and co‑director of the Yale Lupus Program, is dedicated to patient-centered lupus research and care.

When Yale School of Medicine's Sherry Mansour, MD, first began her training at Yale, she was struck by the high rates of heart failure among her patients with kidney disease. Mansour set out to better understand the biological link between kidney injury and heart failure, aiming to identify patients at the highest risk and ensure they receive timely preventive measures, primary care follow-up, and specialist referrals.

Yale School of Medicine's F. Perry Wilson, MD, discusses early-onset colorectal cancer, how women's ovulation impacts the moods of others, and a rare condition surging due to the legalization of marijuana.

Meet Melissa Shaw, research associate in Yale School of Medicine's Clinical and Translation Research Accelerator, who plays a key role in the development, implementation, and oversight of various research studies.

The 2025 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award of The Department of Internal Medicine was presented to two recipients: Benjamin Y. Lu, MD, PhD, of Medical Oncology and Hematology, and Abinet M. Aklilu, MD, MPH, of Nephrology on June 26, 2025.

Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children. Their findings were published in the Journal of the American Society of Nephrology.

The Novavax vaccine is one of three vaccines that are FDA-approved in the United States for the prevention of COVID-19. Yale Medicine answers commonly asked questions about the shot.

Yale School of Medicine's F. Perry Wilson comments on how virtual reality could be used to diagnose ADHD.